QA: Bellicum Pharmaceuticals INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2022_Bellicum_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001358403, Bellicum Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 49,131,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,000
3 remainder_Assets 0
4 LiabilitiesCurrent 6,712,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,311,699
9 ResearchAndDevelopmentExpense 1,135,655
10 remainder_Expenses 0
11 remainder_Revenues 359,716
12 remainder_NetIncome 28,358,873
13 remainder_ComprehensiveNetIncome -11,999
  yvar yval
0 Assets 49,143,000
1 Liabilities 6,712,000
2 Expenses 3,447,354
3 Revenues 359,716
4 StockholdersEquity 42,431,000
5 NetIncome 25,271,235
6 ComprehensiveNetIncome 25,265,236
7 BaseVar 44,016,471
8 EconomicCapitalRatiobeforeLimitedLiability 4.22
9 EconomicCapitalRatio 4.56

Edgar->Model Mapping

Feature Distribution

Change over Time